HIV i-Base/Treatment Action Group 2012 Pipeline Report Reveals Deep Gaps between Scientific Promise and Program Delivery
2012 Pipeline Report
TAG and the TB CAB Send Open Letter to Otsuka
TAG and TB CAB Issue Open Letter to Janssen
TAG and TB CAB Letter On Drug-Drug Interaction in TB Drug Development
Letter to the EMA: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783)
May 24, 2012 TO: Marco Cavaleri CC: Hans-Georg Eichler European Medicines Agency 7 Westferry Circus- Canary Whar London E14 4 HB United Kingdom RE: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783) Dear Dr. Cavaleri, We wish to draw…
Two New TAG Publications
Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…
Message to the New President: Join Us in the Fight Against AIDS
Recommendations submitted by Treatment Action Group to President Barack Obama on ways to strengthen the struggle to end AIDS Demonstrate Strong Domestic and Global Leadership TAG urges President Obama to make fighting AIDS a national and global priority through…
TAG at the Union, 2008: The Impact of Activism on TB
The Union Conference provides an important opportunity for TAG to exert its activist influence on all of the key people in the fight against TB. By Javid Syed The tuberculosis universe convenes once a year at the World Conference on…